Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catechol O-Methyltransferase | 10 | 2019 | 251 | 4.390 |
Why?
|
| Placebo Effect | 10 | 2020 | 514 | 2.940 |
Why?
|
| Pharmacogenetics | 5 | 2020 | 682 | 1.260 |
Why?
|
| Lifting | 1 | 2023 | 56 | 0.830 |
Why?
|
| Universal Precautions | 1 | 2022 | 34 | 0.820 |
Why?
|
| Irritable Bowel Syndrome | 3 | 2017 | 454 | 0.690 |
Why?
|
| Masks | 1 | 2022 | 209 | 0.680 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2023 | 16047 | 0.680 |
Why?
|
| Nedocromil | 1 | 2019 | 45 | 0.670 |
Why?
|
| Blood Sedimentation | 1 | 2020 | 233 | 0.650 |
Why?
|
| School Health Services | 1 | 2022 | 387 | 0.630 |
Why?
|
| alpha-Tocopherol | 1 | 2019 | 127 | 0.620 |
Why?
|
| Budesonide | 1 | 2019 | 163 | 0.610 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2019 | 162 | 0.600 |
Why?
|
| Residence Characteristics | 2 | 2024 | 2116 | 0.570 |
Why?
|
| Drugs, Investigational | 1 | 2019 | 211 | 0.570 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2020 | 10383 | 0.560 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 2741 | 0.550 |
Why?
|
| Clonidine | 1 | 2016 | 165 | 0.500 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2016 | 90 | 0.500 |
Why?
|
| Aspirin | 2 | 2019 | 3134 | 0.490 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 778 | 0.470 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2016 | 217 | 0.470 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 572 | 0.460 |
Why?
|
| Neuralgia | 2 | 2018 | 625 | 0.400 |
Why?
|
| Pain Measurement | 2 | 2020 | 3561 | 0.400 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1084 | 0.390 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 3850 | 0.370 |
Why?
|
| Health Policy | 1 | 2022 | 2698 | 0.340 |
Why?
|
| Cardiovascular Diseases | 5 | 2021 | 15652 | 0.330 |
Why?
|
| Research Design | 4 | 2019 | 6209 | 0.290 |
Why?
|
| Placebos | 3 | 2018 | 1659 | 0.270 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2020 | 3733 | 0.240 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 8041 | 0.230 |
Why?
|
| Occupational Groups | 1 | 2022 | 5 | 0.210 |
Why?
|
| Hypnosis | 1 | 2023 | 83 | 0.210 |
Why?
|
| Students | 2 | 2023 | 1734 | 0.210 |
Why?
|
| Genetic Variation | 2 | 2015 | 6610 | 0.210 |
Why?
|
| Stress, Psychological | 1 | 2018 | 4533 | 0.200 |
Why?
|
| Hepatitis B Vaccines | 1 | 2022 | 178 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 18071 | 0.180 |
Why?
|
| Immunization Schedule | 1 | 2022 | 228 | 0.180 |
Why?
|
| Asthma | 1 | 2019 | 6270 | 0.180 |
Why?
|
| Humans | 33 | 2024 | 765968 | 0.170 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 6544 | 0.170 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 326 | 0.160 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 1740 | 0.160 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2020 | 228 | 0.150 |
Why?
|
| Education | 1 | 2021 | 533 | 0.150 |
Why?
|
| Incidence | 3 | 2023 | 21480 | 0.150 |
Why?
|
| Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
| beta Carotene | 1 | 2019 | 522 | 0.140 |
Why?
|
| Genotype | 3 | 2019 | 13024 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2020 | 3425 | 0.140 |
Why?
|
| Delirium | 2 | 2019 | 1707 | 0.140 |
Why?
|
| Vital Capacity | 1 | 2019 | 995 | 0.130 |
Why?
|
| Orthostatic Intolerance | 1 | 2016 | 22 | 0.130 |
Why?
|
| Alleles | 2 | 2019 | 6897 | 0.130 |
Why?
|
| Plant Oils | 1 | 2017 | 199 | 0.130 |
Why?
|
| Semaphorins | 1 | 1996 | 96 | 0.130 |
Why?
|
| Boston | 3 | 2024 | 9338 | 0.130 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 856 | 0.130 |
Why?
|
| Double-Blind Method | 3 | 2020 | 12437 | 0.130 |
Why?
|
| Cough | 1 | 2019 | 597 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2019 | 65188 | 0.120 |
Why?
|
| Respiratory Sounds | 1 | 2019 | 705 | 0.120 |
Why?
|
| Norway | 1 | 2016 | 499 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1066 | 0.110 |
Why?
|
| Genetics | 1 | 2015 | 114 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1325 | 0.110 |
Why?
|
| Female | 16 | 2020 | 396112 | 0.110 |
Why?
|
| Quality of Life | 3 | 2023 | 13462 | 0.110 |
Why?
|
| Schools | 1 | 2022 | 1492 | 0.110 |
Why?
|
| Male | 15 | 2020 | 363698 | 0.110 |
Why?
|
| Neoplasms | 2 | 2019 | 22340 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1159 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2024 | 1880 | 0.100 |
Why?
|
| Gastrointestinal Agents | 1 | 2017 | 510 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2019 | 1187 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 12240 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2015 | 23601 | 0.100 |
Why?
|
| Homozygote | 1 | 2016 | 1775 | 0.090 |
Why?
|
| Fatigue | 1 | 2018 | 1549 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 841 | 0.090 |
Why?
|
| Neurotransmitter Agents | 1 | 2015 | 663 | 0.090 |
Why?
|
| Middle Aged | 10 | 2020 | 223009 | 0.090 |
Why?
|
| Personality | 1 | 2014 | 560 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2021 | 1940 | 0.090 |
Why?
|
| Poverty | 1 | 2022 | 2714 | 0.090 |
Why?
|
| Dopamine | 1 | 2018 | 1582 | 0.090 |
Why?
|
| Vitamin E | 1 | 2014 | 869 | 0.080 |
Why?
|
| Haplotypes | 1 | 2016 | 2728 | 0.080 |
Why?
|
| Massachusetts | 1 | 2022 | 8875 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 1370 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2016 | 3624 | 0.080 |
Why?
|
| Motivation | 1 | 2018 | 2018 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 12807 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2019 | 24282 | 0.070 |
Why?
|
| Adult | 9 | 2023 | 223044 | 0.070 |
Why?
|
| Antigens, CD | 1 | 1996 | 4025 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 1996 | 3690 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 5501 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3458 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 7123 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2895 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2019 | 54802 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3424 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 1996 | 4778 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2012 | 6322 | 0.050 |
Why?
|
| Monoamine Oxidase | 1 | 2023 | 179 | 0.050 |
Why?
|
| Young Adult | 4 | 2020 | 59889 | 0.050 |
Why?
|
| Pain | 1 | 2018 | 5077 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 7599 | 0.050 |
Why?
|
| Aged | 6 | 2020 | 171117 | 0.050 |
Why?
|
| Child | 3 | 2023 | 80564 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2016 | 6424 | 0.050 |
Why?
|
| Adolescent | 3 | 2020 | 88835 | 0.040 |
Why?
|
| Cognition | 1 | 2018 | 7049 | 0.040 |
Why?
|
| Sleep | 1 | 2016 | 4813 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 59489 | 0.040 |
Why?
|
| Recombination, Genetic | 2 | 1995 | 1525 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12509 | 0.040 |
Why?
|
| Anxiety | 1 | 2014 | 4671 | 0.040 |
Why?
|
| Review Literature as Topic | 1 | 2021 | 297 | 0.040 |
Why?
|
| Suggestion | 1 | 2018 | 21 | 0.040 |
Why?
|
| Carbidopa | 1 | 2018 | 30 | 0.040 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 741 | 0.040 |
Why?
|
| Phenotype | 1 | 2016 | 16721 | 0.040 |
Why?
|
| Risk Factors | 2 | 2016 | 74840 | 0.040 |
Why?
|
| Mentha piperita | 1 | 2017 | 18 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 8730 | 0.040 |
Why?
|
| Genetic Complementation Test | 2 | 1995 | 557 | 0.030 |
Why?
|
| Levodopa | 1 | 2018 | 222 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2018 | 186 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1069 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 1996 | 238 | 0.030 |
Why?
|
| Haloperidol | 1 | 2018 | 391 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15747 | 0.030 |
Why?
|
| Radiation Tolerance | 2 | 1995 | 475 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2018 | 644 | 0.030 |
Why?
|
| Receptors, IgE | 1 | 1996 | 374 | 0.030 |
Why?
|
| COS Cells | 1 | 1996 | 1136 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15880 | 0.030 |
Why?
|
| Lidocaine | 1 | 2018 | 550 | 0.030 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1994 | 111 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 1995 | 182 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1994 | 451 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39193 | 0.030 |
Why?
|
| Condoms | 1 | 2014 | 336 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2745 | 0.020 |
Why?
|
| Vitamins | 1 | 2020 | 1630 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 29922 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1996 | 1965 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2077 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1441 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4165 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 1015 | 0.020 |
Why?
|
| Animals | 4 | 2018 | 168764 | 0.020 |
Why?
|
| Sexual Partners | 1 | 2014 | 804 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2739 | 0.020 |
Why?
|
| DNA Helicases | 1 | 1995 | 852 | 0.020 |
Why?
|
| Computational Biology | 1 | 2021 | 3559 | 0.020 |
Why?
|
| Self Report | 1 | 2020 | 3770 | 0.020 |
Why?
|
| Transfection | 1 | 1996 | 5743 | 0.020 |
Why?
|
| Focus Groups | 1 | 2014 | 1459 | 0.020 |
Why?
|
| HIV Infections | 1 | 2014 | 17533 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 6493 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 17594 | 0.020 |
Why?
|
| Cell Survival | 1 | 1996 | 5747 | 0.020 |
Why?
|
| Urban Population | 1 | 2014 | 2040 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2020 | 9347 | 0.020 |
Why?
|
| DNA Repair | 1 | 1995 | 2048 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 13400 | 0.010 |
Why?
|
| United States | 2 | 2024 | 72903 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1996 | 12768 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2014 | 3139 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 7838 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 3230 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1995 | 5783 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26318 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1996 | 11641 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1996 | 11888 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1995 | 9601 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40065 | 0.010 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1994 | 37 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1994 | 421 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1995 | 295 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1994 | 419 | 0.010 |
Why?
|
| Gamma Rays | 1 | 1994 | 324 | 0.010 |
Why?
|
| CHO Cells | 1 | 1995 | 1372 | 0.010 |
Why?
|
| Cricetinae | 1 | 1995 | 2411 | 0.010 |
Why?
|
| Mutation | 1 | 1995 | 30198 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1994 | 1216 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1994 | 2630 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 81514 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1994 | 4618 | 0.000 |
Why?
|
| DNA Damage | 1 | 1995 | 2457 | 0.000 |
Why?
|
| Base Sequence | 1 | 1994 | 12403 | 0.000 |
Why?
|
| DNA | 1 | 1995 | 7202 | 0.000 |
Why?
|
| Cell Line | 1 | 1995 | 15543 | 0.000 |
Why?
|
| Mice | 1 | 1994 | 81819 | 0.000 |
Why?
|
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_